Search bioRxiv⌕ Search

Biology subjects

Qingyi, M.

Publications and source records attributed to Qingyi, M..

2 recordsLinked to original sources

High-PepBinder: A pLM-Guided Latent Diffusion Framework for Affinity-Aware Target-Specific Peptide Design

Peptides, as therapeutic molecules, offer unique advantages in targeting complex protein surfaces, yet their rational design remains limited by the vastness of the sequence space and the constraints of traditional approaches. Here, we propose High-PepBinder, a sequence-only conditional diffusion framework for target-specific peptide generation. Guided by the target protein sequence, High-PepBinder adopts a dual encoder architecture that integrates protein language models (pLMs) with the diffusion model. This approach cascades the peptide generation model with an affinity classifier and enables the generation process to capture affinity-related features of the peptides through lightweight joint optimization. Due to the scarcity of protein-peptide affinity data, we constructed PepPBA, to our knowledge the most comprehensive dataset to date, and established a structure- and physics-based screening pipeline to prioritize top candidates. Results show that High-PepBinder demonstrates competitive performance across multiple peptide generation and affinity-related tasks. For representative targets, including KEAP1, XIAP, and EGFR, the generated peptides preserve key binding geometries and interface patterns of reference peptides in predicted complexes, while maintaining sequence diversity and favorable predicted properties. Overall, High-PepBinder contributes toward a general and sequence-only strategy for peptide design, offering a computational framework for expanding peptide discovery against challenging targets.

bioinformatics↗

MeDCycFold: A Rosetta Distillation Model to Accelerate Structure Prediction of Cyclic Peptides with Backbone N-methylation and D-amino Acids

Cyclic peptides with backbone N-methylated amino acids(BNMeAAs) and D-amino acids(D-AAs) have gained attention for their stability, membrane permeability, and other therapeutic potentials. Currently, Rosetta can predict their structures using energy calculations, but this method is heavily time-consuming. Moreover, structural data for cyclic peptides containing BNMeAAs and D-AAs are extremely insufficient to build a data-driven structure prediction model. To address these problems, we propose MeDCycFold, a deep learning-based Rosetta distillation model by fine-tuning the AlphaFold model. First, a cyclic peptide structure dataset is constructed using Rosetta by sampling massive conformations for cyclic peptides with BNMeAAs and D-AAs and evaluating their energy scores. Then, the AlphaFold model is fine-tuned with the extended 56 BNMeAAs and D-AAs. Besides, a relative position cyclic matrix is introduced for head-to-tail cyclization in the cyclic peptides. Finally, a force field is employed to reduce clashes in the predicted structures. Empirical experiments show that our proposed MeDCycFold speeds up structure prediction by 49 times while maintaining the prediction accuracy comparable to Rosetta, which can greatly accelerate the development of cyclic peptide drugs.

bioinformatics↗